Recently, the prognostic value of Annexin A1 expression has been reported in lung cancer, head neck cancer, bladder cancer and breast cancer [18-24], most of which report Annexin A1 overexpression indicates a poorer prognosis. This evidence concerns the gene ANXA1 and urinary bladder carcinoma.